Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Twist Bioscience Corporation
TWST | US
24.51
USD0.49
2.04%
TWST | US
About Twist Bioscience Corporation
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/09/2023
As of date
29/11/2023
Close
24.51
Open
24.29
High
25.61
Low
24.01
Twist Bioscience Corporation a synthetic biology company manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products including synthetic genes tools for sample preparation antibody libraries for drug discovery and development and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. The company was incorporated in 2013 and is headquartered in South San Francisco California.
View LessTWST | US
Risk
113.8%
Sharpe
-0.10
Luna's Score
54/100
Recommendation
Hold
Luna says (TWST | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
No Dividends (Dividend Yield = 0%)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
136.8%1 month
113.8%3 months
85.9%6 months
77.9%Return
Fundamental Ratios
PE
0
Fwd. PE
0
Price to book
1.90
Debt to equity
0.15
Debt to assets
0.12
Ent. to EBITDA
-5.14
Ent. to rev.
5.35
PEG
0
Other Fundamentals
EBITDA
-181.06M
MarketCap
1.41B
MarketCap(USD)
1.41B
Div. yield
0
Op. margin
-74.81
Erngs. growth
0
Rev. growth
16.80
Ret. on equity
-28.97
Short ratio
16.79
Short perc.
29.83
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
6.98
Range1M
11.35
Range3M
11.35
Volumes: Market Activity
Rel. volume
1.52
Price X volume
42.64M
